DEF8 inhibitors represent a class of small molecules that target the activity of the protein DEF8 (Differentially Expressed in FDCP 8). DEF8 is a cytoplasmic protein associated with cellular functions such as membrane trafficking, vesicle formation, and intracellular signaling pathways. Structurally, DEF8 contains pleckstrin homology (PH) domains, which are crucial for interactions with phospholipids and other membrane-associated proteins. Inhibition of DEF8 disrupts these interactions, leading to alterations in intracellular dynamics, specifically affecting endosomal and lysosomal trafficking. The inhibitors often work by binding to key domains in DEF8, preventing its association with other proteins or lipids, thereby modulating the downstream processes it regulates.
These inhibitors are of significant interest in the study of cellular transport mechanisms and protein interactions. By blocking DEF8's function, researchers can observe how certain pathways are altered, providing insight into its role in vesicle formation and recycling. Additionally, DEF8 inhibitors are used to study how membrane-bound compartments such as lysosomes or endosomes move within the cell and interact with the cytoskeleton. Since DEF8 plays a role in regulating the localization and movement of these structures, inhibiting its activity allows for a deeper understanding of the protein's function in maintaining cellular homeostasis and structure. This makes DEF8 inhibitors valuable tools for exploring basic cellular processes and their regulatory mechanisms.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, possibly affecting DEF8 activity by altering PI3K/Akt signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can regulate protein synthesis and may affect DEF8 indirectly through mTOR signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, possibly affecting DEF8 by altering cellular responses to stress and inflammation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, potentially affecting DEF8 activity through the MAPK/ERK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, which can disrupt signaling pathways that may intersect with DEF8's role. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which may modulate DEF8 activity by impacting the MAPK/ERK pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, potentially affecting DEF8 by altering downstream signaling mechanisms. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could affect DEF8 activity by modulating stress response pathways. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Disrupts Rac1, potentially influencing DEF8 function through changes in actin cytoskeletal dynamics. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can impact DEF8 by altering protein degradation pathways. | ||||||